EGCG up-regulates TUG1 to inhibit the Hippo/YAP pathway activity caused by TNF-α and to improve biological functions of MC3T3-E1 cells, suggesting EGCG can effectively alleviate TNF-α-caused adverse effects in osteoporosis. The gene discussed is TUG1; the disease is osteoporosis.